ArticleOncoTargets and therapy2025

Targeting the Inactive Conformation of the Epidermal Growth Factor Receptor Identifies EG31: A Novel Small Molecule Inhibitor Effective Against Normal and 5-Fluorouracil-Resistant Triple Negative Breast Cancer Cells.

Hassan M OtifiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.